1.
Sante Publique
; 28(6): 781-789, 2016 Dec 19.
Artigo
em Francês
| MEDLINE
| ID: mdl-28155773
RESUMO
Increased costs cannot be exclusively attributed to the consequences of insulin prescription. Any initiative designed to accelerate acquisition of patient autonomy would be likely to reduce the costs observed after switching to insulin, provided this initiative is adapted to the patient’s health profile, diabetes history and available medical resources..